News, trends, and stories from the synthetic biology industry

Hi all,

Thanks to Tim Gardner, founder and CEO of Riffyn, for sponsoring this week's SynBioBeta newsletter. Twenty years ago, he wrote a seminal paper with Jim Collins on a biological toggle switch, which launched the field and the industry. Tim's since gone on to found Riffyn to help scientists spend less time sorting through mountains of data and more time asking important questions. I'm a big fan and you can sign up for a demo here: Riffyn.com
 

For the first time ever, SynBioBeta is hosting Brands and Biology, a virtual, interactive two-day event focused on how synthetic biology is building more sustainable, higher performance products.

Daniel Meyer (Spiber), Emily Leproust (Twist Bioscience), Kevin Ness (Inscripta), John Cumbers (SynBioBeta), Jason Kelly (Ginkgo Bioworks), and Eric Hobbs (Berkeley Lights). In this photo at SynBioBeta 2019, I am wearing the world’s first outerwear jacket made with spider silk, by Spiber, and showing Checkerspot's brewed protein skateboard. 

Join us on December 2nd and 3rd for Brands and Biology, an exciting and thought-provoking series of talks, roundtables, and networking events on the consumer biotech revolution. We’ll explore topics such as:

  • Consumer attitudes towards and engagement with bio-based ingredients and products
  • Synthetic biology’s disruption of the fashion, food, cosmetics, electronics, and construction industries
  • How to build a consumer-facing synthetic biology brand and succeed in a crowded marketplace

Secure your spot today and take advantage of our Early Bird ticket pricing until November 19th at midnight.

Speakers include:

Gavin McIntyre
Ecovative Design

 

Charles Dimmler
Checkerspot

Jasmina Aganovic
Ginkgo Bioworks

Register now

Twist Bioscience, Illumina and Western Digital recently formed an alliance with Microsoft to advance data storage in DNA. In addition to developing an industry roadmap, the DNA Data Storage Alliance plans to develop use cases in various markets and industries as well as promote and educate the larger storage community to promote adoption of this future solution.

In funding news:

Regards, 
John

Can we recreate every human cell type in the body? This UK startup thinks so. Bit Bio, a UK synthetic biology startup backed by Silicon Valley investors, has partnered with the London Institute for Mathematical Sciences, marking a milestone in the fusion of biology and mathematics for coding human cells.

Latest News

Biosensors printed directly on skin bring wearable tech to next level (Forbes)

Locus Biosciences signs contract with CARB-X to advance $14 million precision medicine program to develop crPhage™ product targeting Klebsiella pneumoniae infections (Press release)

Researchers at Goethe University create artificial cell organelles for biotechnology

Webinar: Use Diverse Native Sequences and Directed Evolution to Improve Enzyme Activity on Target Reactions

Synthetic biology and the environment: SynBio opens new environmental sustainability possibilities for pharma (Pharm Exec Magazine)

Beckman Coulter Life Sciences acquires microbioreactor manufacturer m2p-labs (Press release)

Twist Bioscience expands infectious disease product line adding comprehensive viral panel (Press release)

Moderna’s Covid-19 vaccine is strongly effective, early look at data show (STAT News)

64x Bio emerges from stealth to drive an evolution in cell and gene therapy manufacturing (Press release)

Intellia Therapeutics receives grant to develop curative CRISPR/Cas9 in vivo sickle cell disease treatments (Press release)

Microbes could be used to extract metals and minerals from space rocks (MIT Tech Review)

Engineering a way out of climate change: Genetically modified organisms could be the key (Phys.org)

ŌGI Bio is developing affordable and innovative solutions for automation and analysis of microbial culturing (bacteria, yeast or algae)

Nimbus Therapeutics is using VR solutions from Nanome and Oculus to help design breakthrough medicines

Precigen announces dosing of first patients with UltraCAR-T® cells manufactured using UltraPorator™ System (Press release)

Who's hiring?

Senior Director: Conagen – Bedford, MA


Scientist, Synthetic Biologist: Novome Biotechnologies – South San Francisco, CA

Biomolecular Nanomaterials Scientist: Berkeley Lab – Bay Area, CA

Graphic Designer: SynBioBeta (contractor)

Head of Sales: SynBioBeta – Pleasant Hill, CA

Applications Analyst (LIMS): Geltor – San Leandro, CA

Business Systems Administrator: Geltor – San Leandro, CA

Marketing Communications Manager/Sr. Manager: DNA Script – South San Francisco or Paris, France
 

Senior Research Associate, Strain Engineering: Flagship Pioneering – Cambridge, MA

 

Synbionik – Germany, Multiple Positions

Codexis – Redwood City, CA, Multiple Positions

AbSci – Vancouver, WA, and Boston, MA Multiple Positions

 

Postdoctoral Research Fellow (Gene Delivery): John A. Burns School of Medicine – Honolulu, HI

 

Scientist, Synthetic Biology: Empress Therapeutics, Inc. – Cambridge, MA

 

Scientist: Palamedrix – San Diego, CA


Senior Scientist, Biochemistry: Inscripta – Pleasanton, CA

Product Manager (Synthetic Biology): Twist Bioscience – San Francisco, CA

Director, Bioinformatics: LifeMine – Cambridge, MA

Staff Engineer, Process Development: Inscripta – San Diego, CA
 

Molecular Biology Team Lead: Slone Partners – San Carlos, CA

 

COVID Test Processor: OpenCell – Jersey, UK

 

Biochip Design Engineer: Analog Devices – Boston, MA

 

Postdoctoral fellow: GartonLab – Toronto, Canada

 

Postdoctoral Research Fellow (Gene Delivery): John A. Burns School of Medicine – Honolulu, HI

 

Scientist, Synthetic Biology: Empress Therapeutics, Inc. – Cambridge, MA

 

 

Feature your job here